Perceptive Advisors
Biotech Investor · 6 portfolio companies
Portfolio
6
Combined Value
$368.6M
Focus Areas
10
Top Stage
Phase 1
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Nautilus Biotechnology | $356.5M |
| LianBio | $12.2M |
| Advanced Cellular Dynamics | — |
| Axonis Therapeutics | — |
| Adaptilens | — |
| Yarrow Bioscience | — |